CompletedNot Applicable

Clinical Trial on Alzheimer Disease, Presbycusis and Hearing Aids

France51 participantsStarted 2007-05

Plain-language summary

This is a 12-months' randomized clinical trial that aims at studying the benefit of bilateral hearing aids in hearing impaired patients suffering from a slight to moderate stage Alzheimer disease. The benefit of this intervention will be studied in the cognitive, behavioural, quality of life and economic fields. 2groups are involved in this trial: Intervention group: 12 months' treatment with active hearing aids, fitted hearing impairment Control group: 6 months' treatment with placebo hearing aids, followed with 6 months' active hearing aids, fitted hearing impairment

Who can participate

Age range65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * \> 65 year-old * Medical diagnosis of Alzheimer disease * 15 ≤ MMSE ≤ 25 * No hearing aids in the last 2 years * Motivated caregiver living with the patient * Sensorineural hearing loss Exclusion Criteria: * Beginning of an anticholinesterasic treatment in the last 6 months * Change in the anticholinesterasic treatment in the last 2 months

What they're measuring

Cognitive benefit evaluated thanks to the ADAS-Cog scale

Timeframe: Times of measurements: 0, 6th and 12th month

Trial details

NCT IDNCT00488007

SponsorHospices Civils de Lyon

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2013-06

View on ClinicalTrials.gov More Alzheimer Disease trials